Delivery Order SPE2DE24D0021-SPE2D626F91A5
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. has been awarded a $4.3K delivery order for BinaxNOW COVID-19 antigen testing kits under a fixed-price contract with economic price adjustment provisions. The award was issued on January 7, 2026, with an ultimate completion date of January 14, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, indicating open competition, and is funded by the Department of Defense's Medical Supply Chain...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,822.94 on April 24, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, which represents no set-aside designation, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of May 1, 2025. This delivery order is structured with economic price adjustment provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. Fisher...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,156 to Fisher Scientific Company L.L.C. on November 20, 2025, for the provision of BinaxNOW COVID-19 antigen testing kits. This is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract carries no set-aside designation, indicating Fisher Scientific competed for this award in an open procurement environment. Performance will...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 4, 2025, for BinaxNow COVID-19 antigen over-the-counter rapid test kits (12 tests per 2-count case) valued at $1,311.20. This fixed-price delivery order with economic price adjustment was issued by the Medical Supply Chain division within the Department of Defense and is set to be completed by August 11, 2025. The contract represents a child award under a larger vehicle and specifies performance in Pittsburgh,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F91A5Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,940 on January 8, 2026, for BinaxNOW COVID-19 antigen testing kits to support the Defense Department's Medical Supply Chain. The contract is a fixed-price delivery order with economic price adjustment provisions, with a completion deadline of January 15, 2026. As a child contract, this award represents an individual order issued under a larger indefinite delivery vehicle or blanket purchase agreement. No set-aside designation was applied, indicating this procurement competed in an open federal marketplace. The place of performance is Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal operations. Fisher Scientific, a long-established federal vendor registered in the System for Award Management since July 2001, specializes in providing laboratory equipment, scientific products, and medical supplies to federal agencies. The company maintains an extensive portfolio of contracts with the Department of Defense, Department of Veterans Affairs, and various civilian health agencies, including the National Institute of Allergy and Infectious Diseases and the Indian Health Service. This award reflects Fisher Scientific's demonstrated capacity to rapidly deliver specialized diagnostic testing supplies supporting federal healthcare and pandemic response initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/7/26 |